Injective EVM Integration Enables Dual DeFi Execution
Injective has deployed a native Ethereum Virtual Machine (Injective EVM) into its layer-1 protocol, creating a dual-execution environment. The Injective EVM embeds EVM alongside Cosmos-based WebAssembly (WASM), letting developers run Ethereum apps and Cosmos-native dApps on a shared liquidity layer. Over 30 dApps and infrastructure providers are live on the upgraded mainnet.
The Injective EVM offers Ethereum tooling like Hardhat and Foundry, plus plug-and-play modules for derivatives, lending, and tokenized real-world assets. Its shared central limit order book and MultiVM Token Standard eliminate bridging friction, deliver MEV-resistant liquidity, and solve DeFi’s cold-start issues. With sub-second finality and minimal fees, the upgrade aims to boost DeFi innovation and cross-chain interoperability, positioning Injective as a code-neutral hub bridging Ethereum, Cosmos, and future Solana VM support.
Bullish
By integrating a native Ethereum Virtual Machine, Injective significantly lowers entry barriers for Ethereum developers and drives on-chain activity. Historically, layer-1 chains like Avalanche and Fantom saw token demand and ecosystem growth soar after EVM adoption. Injective EVM’s shared order book and MEV-resistant liquidity further enhance value capture on-chain. In the short term, this upgrade should spur network usage and positive sentiment, likely exerting upward price pressure on INJ. Over the long term, dual-execution support and cross-chain interoperability can cement Injective’s role as a major DeFi hub, underpinning sustained ecosystem expansion and token appreciation — a bullish catalyst for traders.